Biocon gets drug controller’s gesture for CytoSorb gadget to treat basic COVID-19 patients Kumar Jeetendra | May 27, 2020 Biocon on May 27 said its auxiliary Biocon Biologics has gotten the Drugs Controller General of India (DCGI) endorsement for extracorporeal blood refinement (EBP) gadget CytoSorb to diminish ace fiery cytokines levels in affirmed COVID-19 patients admitted to the emergency unit with affirmed or inescapable respiratory disappointment. Biocon Biologics has been conceded the permit for …
